InsiderTrades

Form 4 for PRTA PROTHENA CORP PUBLIC LTD CO

Accepted 2023-06-07 00:00:00 ET · period of report 2023-06-07 · accession 0001140361-23-028870 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DMT 2023-06-07 2023-06-07 PRTA Zago Wagner M. CSO S - Sale+OE $71.06 -19.0K 0 -100% -$1.35M
DMT 2023-06-07 2023-06-07 PRTA Zago Wagner M. CSO M - OptEx $26.09 +19.0K 19.0K New +$495.8K
DMT 2023-06-07 2023-06-07 PRTA Zago Wagner M. CSO M - OptEx $0.00 -19.0K 66.0K -22% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Ordinary Shares, par value $0.01 per share 2023-06-07 S D 3,759 $71.96 294 D — — (F4) The transaction was executed in multiple trades in prices ranging from $71.57 to $72.41, inclusive.
2 Common Ordinary Shares, par value $0.01 per share 2023-06-07 S D 12,004 $70.99 4,053 D — — (F3) The transaction was executed in multiple trades in prices ranging from $70.545 to $71.4925, inclusive.
3 Common Ordinary Shares, par value $0.01 per share 2023-06-07 M A 15,000 $29.81 15,000 D — —
4 Common Ordinary Shares, par value $0.01 per share 2023-06-07 M A 4,000 $12.15 19,000 D — —
5 Common Ordinary Shares, par value $0.01 per share 2023-06-07 S D 2,943 $70.02 16,057 D — — (F2) The transaction was executed in multiple trades in prices ranging from $69.54 to $70.53, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the ranges set forth in footnotes 2 through 4 of this Form 4.
6 Common Ordinary Shares, par value $0.01 per share 2023-06-07 S D 294 $73.14 0 D — —
7 Derivative Stock Option (Right to Buy) 2023-06-07 M D 15,000 $0.00 0 D $29.81 · — to 2024-02-04 15,000 Ordinary Shares (F5) All shares subject to the option have fully vested.
8 Derivative Stock Option (Right to Buy) 2023-06-07 M D 4,000 $0.00 66,000 D $12.15 · — to 2030-02-25 4,000 Ordinary Shares (F6) The shares subject to the option vested and became exercisable as to 25% of the total number of shares subject to the option on February 25, 2021, and vest and become exercisable with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.